Cambridge Investment Research Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.46M Buy
38,298
+6,029
+19% +$511K 0.01% 1273
2026
Q1
$2.7M Buy
32,269
+4,060
+14% +$333K 0.01% 1371
2025
Q4
$2.58M Sell
28,209
-522
-2% -$50K 0.01% 1326
2025
Q3
$2.72M Buy
+28,731
New +$2.7M 0.01% 1266
2019
Q2
Sell
-5,105
Closed -$378K 2268
2019
Q1
$378K Buy
+5,105
New +$359K ﹤0.01% 1662
2018
Q4
Sell
-2,223
Closed -$210K 2209
2018
Q3
$210K Buy
+2,223
New +$192K ﹤0.01% 2025

Other funds holding HQY

Cambridge Investment Research Advisors's HQY Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its HealthEquity (HQY) stake by 19% in Q2 2026, buying an estimated $511K and bringing the position to 38,298 shares worth $3.46M. The position accounts for 0.01% of the portfolio, ranked #1273.

Cambridge Investment Research Advisors first reported a position in HQY in Q3 2018 and has held it in 6 quarters since. 138 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Cambridge Investment Research Advisors held 38,298 shares of HealthEquity worth $3.46M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 6,029 HealthEquity shares in Q2 2026, an estimated $511K.
  • HealthEquity made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1273 holding.
  • Cambridge Investment Research Advisors first reported a position in HealthEquity in Q3 2018 and has held it in 6 quarters since.
  • 138 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.